MXPA05013020A - Tabletas de fumarato de deramciclano. - Google Patents

Tabletas de fumarato de deramciclano.

Info

Publication number
MXPA05013020A
MXPA05013020A MXPA05013020A MXPA05013020A MXPA05013020A MX PA05013020 A MXPA05013020 A MX PA05013020A MX PA05013020 A MXPA05013020 A MX PA05013020A MX PA05013020 A MXPA05013020 A MX PA05013020A MX PA05013020 A MXPA05013020 A MX PA05013020A
Authority
MX
Mexico
Prior art keywords
weight
deramciclane
fumarate
tablets
fumarate tablets
Prior art date
Application number
MXPA05013020A
Other languages
English (en)
Inventor
Pal Dr Fekete
Zsolt Zsigmond
Laszlone Gora
Huszar Magdolna Leventiszne
Istvanne Jambor
Jozsef Tari
Laszlone Dr Maroshelyi
Original Assignee
Egis Gyogyszergar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergar Rt filed Critical Egis Gyogyszergar Rt
Publication of MXPA05013020A publication Critical patent/MXPA05013020A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Abstract

La invencion se relaciona con tabletas que comprenden fumarato de deramiclano de Formula (I) por lo que las tabletas contienen (en relacion al peso total) mas de 50% en peso de fumarato de deramiclano, 5-20% de un aglutinante, 5-20% en peso de celulosa microcristalina que tiene un tamano de particula promedio inferior a 30 (m, 1-10% en peso de un desintegrante, 0.5-4% en peso de un lubricante, 0.5-4% en peso de un agente antiadhesivo y 0-30% en peso de una carga. El fumarato de deramiclano es un ingrediente activo anxiolitico conocido (ver formula (I)).
MXPA05013020A 2003-06-03 2004-06-03 Tabletas de fumarato de deramciclano. MXPA05013020A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301537A HUP0301537A3 (en) 2003-06-03 2003-06-03 Deramcyclane fumarate tablets and process for producing them
PCT/HU2004/000058 WO2004105743A1 (en) 2003-06-03 2004-06-03 Deramciclane-fumarate tablets

Publications (1)

Publication Number Publication Date
MXPA05013020A true MXPA05013020A (es) 2006-03-17

Family

ID=90001686

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013020A MXPA05013020A (es) 2003-06-03 2004-06-03 Tabletas de fumarato de deramciclano.

Country Status (25)

Country Link
US (1) US20060258745A1 (es)
EP (1) EP1628648B1 (es)
JP (1) JP2006526603A (es)
KR (1) KR20060015746A (es)
CN (1) CN1832733A (es)
AT (1) ATE381325T1 (es)
AU (1) AU2004243240A1 (es)
BG (1) BG109404A (es)
BR (1) BRPI0410909A (es)
CA (1) CA2527431A1 (es)
CZ (1) CZ2005817A3 (es)
DE (1) DE602004010803D1 (es)
EA (1) EA009681B1 (es)
HR (1) HRP20050979A2 (es)
HU (1) HUP0301537A3 (es)
IL (1) IL172133A0 (es)
IS (1) IS8202A (es)
MX (1) MXPA05013020A (es)
NO (1) NO20056220L (es)
PL (1) PL378540A1 (es)
RS (1) RS20050898A (es)
SK (1) SK51112005A3 (es)
UA (1) UA80209C2 (es)
WO (1) WO2004105743A1 (es)
ZA (1) ZA200510139B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
CN110973635B (zh) * 2019-12-26 2022-07-29 汤臣倍健股份有限公司 一种辅料组合物及益生菌片剂
CN114643014B (zh) * 2022-05-07 2024-02-13 佛山市锦厨食品科技有限公司 一种可提高颗粒状鸡精的成型速度的食品用造粒机

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
WO2000037055A1 (en) * 1998-12-18 2000-06-29 Abbott Laboratories Controlled release formulation of divalproex sodium
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
DE60212464T2 (de) * 2002-04-29 2007-01-11 EGIS Gyógyszergyár Rt. Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit

Also Published As

Publication number Publication date
KR20060015746A (ko) 2006-02-20
UA80209C2 (en) 2007-08-27
BRPI0410909A (pt) 2006-06-27
WO2004105743A1 (en) 2004-12-09
PL378540A1 (pl) 2006-05-02
IS8202A (is) 2005-12-28
HUP0301537A2 (hu) 2005-03-29
IL172133A0 (en) 2006-04-10
HRP20050979A2 (en) 2006-03-31
CA2527431A1 (en) 2004-12-09
JP2006526603A (ja) 2006-11-24
ATE381325T1 (de) 2008-01-15
BG109404A (en) 2006-11-30
HUP0301537D0 (en) 2003-08-28
CN1832733A (zh) 2006-09-13
EA009681B1 (ru) 2008-02-28
HUP0301537A3 (en) 2005-07-28
DE602004010803D1 (de) 2008-01-31
ZA200510139B (en) 2007-03-28
EA200501883A1 (ru) 2006-06-30
AU2004243240A1 (en) 2004-12-09
US20060258745A1 (en) 2006-11-16
CZ2005817A3 (cs) 2006-04-12
EP1628648B1 (en) 2007-12-19
SK51112005A3 (sk) 2006-06-01
RS20050898A (en) 2008-04-04
NO20056220L (no) 2006-03-02
EP1628648A1 (en) 2006-03-01

Similar Documents

Publication Publication Date Title
MX2007004294A (es) Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion.
RS20080072A (en) Compositions comprising a cholesterol absorbtion inhibitor, and hmg-coa reductase inhibitor and stabilizing agent
GEP20094627B (en) High drug load tablet
WO2007048219A3 (en) Sustained drug release composition
MX2009004746A (es) Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
JO2584B1 (en) Modified Release Formula 1 - ((3-Hydroxyl-Adamant-1-Ylamino) -acetyl) -perrolidine-2 (S) Carbonitrile
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MXPA04011914A (es) Formulacion farmaceutica de liberacion modificada.
MY163503A (en) Aerosol formulations for the inhalation of beta agonists
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
AU2003268342A8 (en) Antimicrobial compositions
EP2210888A3 (en) Stable micronized candesartan cilexetil and methods for preparing thereof
IL172133A0 (en) Deramciclane-fumarate tablets
MX2007014963A (es) Composicion de liberacion modificada de al menos una forma de venlafaxina.
SE0203070D0 (en) Novel compounds
TNSN08546A1 (en) Aminoalcohol derivative and immunosuppressive agent having same as an active ingredient
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
EP1734046A4 (en) radiosensitizing
AU2003286210A1 (en) Smoke composition
EP1510511A4 (en) GINGEROL ANALOGS AND THEIR USE
MX2009001572A (es) Derivados de arilpiperazina y usos de los mismos.
WO2004069228A3 (en) Sustained release formulations of venlafaxine

Legal Events

Date Code Title Description
FA Abandonment or withdrawal